Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

astrazeneca_sign_sky

AstraZeneca’s Farxiga granted Priority Review by FDA

January 6, 2021 Research and Development AstraZeneca, FDA, farxiga

AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney …
News
herbert

Clinigen appoints Sam Herbert as Chief Operating Officer

January 5, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinigen, the global pharmaceutical and services company, has appointed Sam Herbert as Chief Operating Officer with immediate effect.
Appointment
screenshot_2021-01-05_puretech_announces_the_appointment_of_george_farmer_ph_d__as_chief_financial_officer_biospace

PureTech appoints George Farmer as Chief Financial Officer

January 5, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PureTech Health, a clinical-stage biotherapeutics company focused on highly differentiated medicines for devastating diseases, has appointed Dr George Farmer as …
Appointment
top_10_image_2_1_5

Pharmafile.com’s top 10 stories of 2020

December 23, 2020 Research and Development

The COVID-19 pandemic has, unsurprisingly, dominated the news this year. The site’s most popular articles of 2020, focused largely on …
News

BioInvent receives $3m payment for antibodies selected by Pfizer

December 23, 2020 Research and Development BioInvent, Cancer, Pfizer

BioInvent International, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, …
News
european_commission_web

Zogenix gets EU marketing authorisation for anti-seizure drug

December 23, 2020 Research and Development

The European Commission (EC) has granted marketing authorisation for Zogenix’s FINTEPLA (fenfluramine), an oral solution for the treatment of seizures …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

December 23, 2020 Research and Development COVID-19, Vaccine

The United States’ mission to inoculate its population is well underway this week; not only has the FDA given emergency …
News

Vicore Pharma study suggests C21 could complement COVID-19 vaccines

December 23, 2020 Research and Development COVID-19, Vicore Pharma

Vicore Pharma, a Swedish company focused on developing medicines for severe lung disorders, has published data suggesting that its oral …
News
1517679969844

Novavax appoints Rick Crowley as Executive Vice President, Chief Operations Officer.

December 22, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novavax, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has announced the appointment of Rick Crowley to …
Appointment

The importance of ethics and patient centricity in managed and early access programmes

December 21, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how …
Feature
1516998199715

4BIO Capital appoints Akiko Iwasaki to its Scientific Advisory Board

December 21, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

4BIO Capital, an international venture capital firm focused on advanced therapies addressing high unmet medical and social needs, has appointed …
Appointment
stanley_crooke

Ionis founder Stanley T Crooke to retire

December 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ionis Pharmaceuticals has announced that its founder, Dr Stanley T Crooke, will retire from the company and its board of …
Appointment
barry-green-headshot

Sage Therapeutics appoints Barry Greene as CEO

December 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sage Therapeutics, a biopharmaceutical company focused on developing treatments for central nervous system disorders, has appointed Barry Greene as Chief …
Appointment
top10

Top Ten most popular articles on Pharmafile.com this week

December 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, antibody

The top news stories of the past week continue to centre around the COVID-19 pandemic; a new variant of the …
News
1_1

Samsung Biologics names John Rim as CEO and President

December 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Samsung BioLogics

Samsung Biologics has appointed John Rim as the company’s President and CEO. The appointment was made effective immediately and formalised via the …
Appointment
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026